We are sorry, but this program expired on 5/12/2024 12:00:00 AM
Overview
In the wake of the COVID-19 pandemic, 2020 saw a 20% reduction in tuberculosis cases from 2019. This dramatic reduction is owed, in part, to pandemic mitigation procedures. However, as the United States investigates re-opening and resuming normal life, these TB infection numbers could increase as well, along with the likelihood of pharmacist being consulted on treatment.
This case-based investigation of TB will discuss the management of tuberculosis, latent tuberculosis infection (LTBI), and multidrug resistant tuberculosis (MDR-TB), as well as how to manage these conditions when drug-interactions are present.
Handouts
Slide Document :
21106H01_2pp.pdf
Slide Document :
21106H01_6pp.pdf
Financial Support By
PharmCon
Pharmacist
Recognize new treatments in the management of tuberculosis and drug-resistant tuberculosis
Select appropriate preferred and alternative latent tuberculosis infection management therapy
Identify and manage drug-drug interactions
Nurse
Identify and manage drug-drug interactions
Recognize new treatments in the management of tuberculosis and drug-resistant tuberculosis
Select appropriate preferred and alternative latent tuberculosis infection management therapy
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.
In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.
HARDWARE REQUIREMENTS Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
SOFTWARE REQUIREMENTS Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher
NETWORK REQUIREMENTS Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).